Directions for using Single Drug Test Card

(Marijuana Drug (THC) Testing Card Shown here)

Specimen Collection for the test

The INSTANT DRUG CARD is formulated for use with urine specimens. Fresh urine does not require any special handling or pretreatment. The urine specimen must be collected in a clean and dry container. Urine samples should be collected such that testing may be performed as soon as possible after the specimen collection, preferably during the same day. Urine samplem can be collected at any time of the day.

The specimen may be refrigerated at 2-8oC for 2 days or frozen at -20oC for a longer period of time. Specimens that have been refrigerated must be equilibrated to room
temperature prior to testing. Specimens previously frozen must be thawed, equilibrated to room temperature, and mixed thoroughly prior to testing.

Note: Urine specimens, and all materials coming in contact with them, should be handled and disposed as if capable of transmitting infection. Avoid contact with
skin by wearing gloves and proper attire.

Test Procedure

Read “Specimen Collection for the tests ” instructions. Test device, patient’s sample, and controls should be brought to room temperature (20-30oC) prior to testing.
Do not open pouch until ready to perform the test.

1. Remove the test device from the protective pouch (bring the device to room temperature before opening the pouch to avoid condensation of moisture
   on the membrane). In the spaces provided, label the device with patient or control identifications, operator and date. Remove the cap to expose the
   absorbent pads.
2. Immerse the absorbent pads in urine specimen until it is observed that a pink color begins to migrate across the result windows (approximately 30 seconds). Do not allow urine to touch plastic device when immersing the absorbent pads. Remove test from urine and replace the cap to cover
   the absorbent pads. Place the device on a flat surface.
3. Read results within 5 to 8 minutes. Do not read results after 10 minutes.

Testing for drug

(Single drug test card shown here)

Interpretation of Result

(-) Negative:

Two colored lines adjacent to each drug name should be observed in the viewing window. The line in the test region (T) is the drug probe line; the line in the control region (C) is the control line, which is used to indicate proper performance of the device. The test line intensity may be weaker or stronger than that of the control line.

(+) Positive:

Only one colored line appears in the control region (C). The absence of a test line indicates a positive result for that drug.

(-/+) Inconclusive:

A faint, indistinguishable line appears in the test region (T) . While probably suggesting a negative result, the test is inconclusive and suggests that the drug in the panel could be near the cut-off concentration level for detection. Perform a second test or take the sample for more extensive laboratory testing. Because of the quality controls built into the test device, an inconclusive result is highly unlikely.

Invalid:

No line appears in the control region. Under no circumstances should a positive sample be identified until the control (C) line forms in the viewing area. If the control line (C) does not form, the test result is invalid and the test should be repeated.

How to read results

An extremely faint line (barely visible) in the test region indicates that a drug metabolite in the sample may near the cut-off concentration level for the test. Normally, any line in the test area should be interpreted as a negative test. If suspicion or uncertainty remains regarding the test results, there are several options available: The donor can be retested at another time with a new test card and sample, the same sample can be retested using a new test card, or the sample can be evaluated by a testing laboratory. If laboratory confirmation is desired or indicated, please see laboratory Testing

Limitations

1. The One Step Test Strip provides only a qualitative, preliminary analytical result. A secondary analytical method must be used to obtain a confirmed result. Gas Chromatography/Mass Spectrometry (GC/MS) are the preferred confirmatory methods.
2. It is possible that technical or procedural errors, as well as other interfering substances in the urine specimen may cause erroneous results.
3. Adulterants, such as bleach and/or alum, in urine specimens may produce erroneous results regardless of the analytical method used. If adulteration is suspected, the test should be repeated with another urine specimen.
4. Certain medications/pharmaceuticals/compounds may produce a Positive Result.
5. A Positive Result indicates presence of the drug or its metabolites but does not indicate level of intoxication, route of administration or concentration in urine.
6. A Negative Result may not necessarily indicate drug-free urine. Negative Results may be obtained when drug is present but below the cutoff level of the test.
7. The test does not distinguish between drugs of abuse & certain medications
   

QuickDrugScreen.com products have been found to be highly accurate and are guaranteed against defects in labeling & packaging until the stated expiration date.

Regardless, QuickDrugScreen.com will not be held accountable/liable for the outcome of ANY result arising from the use of QuickDrugScreen.com products.

QuickDrugScreen.com is sole obligation in the event of ANY damage/result/defect is to replace it with a comparable new test strip product. Except for such replacement, the sale, transfer, or handling of these drug test products are without warranty, condition or liability even though the damage/result/defect is due to negligence or other fault.